On September 2, 2021 Calithera Biosciences, Inc. (Nasdaq: CALA), a fully-integrated clinical stage biotechnology company focused on discovering and developing novel, small molecule drugs for the treatment of cancer and other life-threatening diseases, reported its participation in two upcoming virtual healthcare investor conferences (Press release, Calithera Biosciences, SEP 2, 2021, View Source [SID1234587156]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual BioPharma Virtual Conference. The Company will host virtual meetings with investors on Wednesday, September 8, 2021.

The 2021 Virtual Wells Fargo Healthcare Conference. Susan M. Molineaux, Ph.D., the company’s founder, president and chief executive officer, will participate in a fireside chat on Thursday, September 9, 2021, at 2:40 p.m. Eastern Time.
A live audio webcast of the Wells Fargo presentation can be accessed through the Investors section of the Company’s website at www.calithera.com. An archived replay of the webcast will be available on the Company’s website for 30 days following the live presentation.